Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter

Kidney International

Volumn 50, Issue 5, 1996, Pages 1684-1693

  Lurbe, Amparo ^b   Fioretto, Paola ^b   Mauer, Michael ^b   Lapointe, Michael S ^b   Batlle, Daniel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CULTURE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FIBROBLAST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE;

EID: 0029907062     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.486     Document Type: Article

References (44)

1. BORCH-JOHNSEN K, ANDERSEN PK, DECKERT T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
2. DECKERT T, POULSEN JE, LARSEN M: Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia 14:363-370, 1978
3. BREYER J: Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis 20:533-547, 1992
4. BOJESTIG M, ARNQUIST H, HERMANSSON G, KARLBERG B, LUDVIGSSON J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1994
5. SEAQUIST ER, GOETZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
6. ANDERSEN A, CHRISTIANSEN J, ANDERSEN J: Diabetic nephropathy in nephropathic type I (insulin dependent) diabetes: An epidemiological study. (abstract) Diabetologia 25:496, 1983
7. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
8. BORCH-JOHNSEN K, NORGAARD K, HOMMEL E, MATHIESEN ER, JENSEN JS, DECKERT T, PARVING HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-22, 1992
9. KROLEWSKI AS, CANESSA M, WARRAM JH, LAFFEL LM, CHRISTLIEB AR, KNOWLER WC, RAND LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
10. JONES S, TREVISAN R, TARIQ T, SEMPLICINI A, MATTOCK M, WALKER J, NOSADINI R, VIBERTI G: Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients. Hypertension 5:570-575, 1990
11. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42:1184-1190, 1992
12. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
13. + exchanger (NHE1). Rev Physiol Biochem Pharmacol 119:157-185, 1992
14. MOE OW, MILLER RT, HORIE S, CANO A, PREISIG PA, ALPERN RJ: Differential regulation of Na/H antiport by acid in renal epithelial cells and fibroblasts. J Clin Invest 88:1703-1708, 1991
15. ALPERN RJ, YAMAJI Y, CANO A, HORIE S, MILLER RT, MOE OW, PREISIG PA: Chronic regulation of the Na/H antiporter. J Lab Clin Med 122:137-140, 1993
16. + exchange and vascular smooth muscle proliferation. Am J Med Sci 307(Suppl 1):S9-S16, 1994
17. + antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81:4833-4837, 1984
18. + exchange inhibitors decrease neointimal formation after rat carotid injury. Circ Res 73:269-275, 1993
19. BOBIK A, GROOMS A, LITTLE P, CRAGOE E, GRINPUKEL S: Ethylisopropyl-amiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth. Am J Physiol 255(Cell Physiol):C581-C588, 1991
20. + exchange. J Clin Invest 83:822-829, 1989
21. MAUER S, STEFFES M, ELLIS E, SUTHERLAND D, BROWN D, GOETZ F: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
22. VIBERTI GC, HILL RD, JARRETT RJ, ARGYROPOULOS A, MAHMUD U, KEEN H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432, 1982
23. MAUER M, MOGENSEN C, FRIEDMAN E: Diabetic nephropathy, in Diseases of the Kidney, edited by SCHRIER R, GOTTSCHALK C, Boston, Little Brown & Co., 1995
24. FIORETTO P, STEFFES MW, MAUER M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43:1358-1364, 1994
25. CHAVERS BM, SIMONSON J, MICHAEL AF: A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 25:576-578, 1984
26. BATLLE DC, PECES R, LAPOINTE MS, YE M, DAUGIRDAS JT: Cytosolic free calcium regulation in response to acute changes in intracellular pH in vascular smooth muscle. Am J Physiol 264(Cell Physiol 33): C932-C943, 1993
27. DAUGIRDAS JT, ARRIETA J, YE M, FLORES G, BATLLE D: Intracellular acidification associated with changes in free cytosolic calcium. J Clin Invest 95:1480-1489, 1995
28. + antiporter (nhe-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney Int 47:78-87, 1995
29. + antiporter of lympohcytes from the spontaneously hypertensive rat. J Clin Invest 85:1734-1739, 1990
30. FRESHNEY RI: Culture of animal cells (chapt 18), in A Manual of Basic Technique (2nd ed), New York, Alan R. Liss Inc., 1987
31. BRADFORD M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye niding. Anal Biochem 72:248-254, 1976
32. TREVISAN R, FIORETTO P, MAUER S, DUNER E, CIPOLLINA M, TREVISAN M, BARBOSA J, NOSADINI R: Concordance for sodium/ hydrogen antiport activity in insulin-dependent diabetic sibling pairs. (abstract) J Am Soc Nephol 5:385, 1994
33. FIORETTO P, STEFFES M, BANBOSA J, SPRAFKA M, MAUER S: Glomerular structure in siblings with insulin-dependent diabetes mellitus. (abstract) J Am Soc Nephrol 2:289, 1991
34. + antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93:2750-2757, 1994
35. GOLDSTEIN S, MOERMAN EJ, SOELDNER JS, GLEASON RE, BARNETT DM: Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science 199:781-782, 1978
36. VRACKO R, BENDITT E: Restricted replicative life-span of diabetic fibroblasts in vitro: Its relation to microangiopathy. Fed Proc 34:68, 1975
37. ROSENBLOOM AL, ROSENBLOOM EK: Insulin-dependent childhood diabetes. Normal viability of cultured fibroblasts. Diabetes 27:338-341, 1978
38. + exchange is not required for induction of hypertrophy of renal cells in vitro. J Am Soc Nephrol 3:1124-1130, 1992
39. + antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase. J Clin Invest 93:2623-2631, 1994
40. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
41. ROOSKOFF D, FROMTER E, SIFFERT W: Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. J Clin Invest 92:2553-2559, 1993
42. + antiporter, type I diabetes, and hypertension (Editorial). Kidney: A Current Survey of World Liturature 4:1-3, 1995
43. LEWIS JL, WARNOCK DG: Renal apical membrane sodium-hydrogen exchange in genetic salt-sensitive hypertension. Hypertension 24:491-498, 1994
44. LAPOINTE M, BATLLE D: Intracellular pH and Na/H exchange in vascular smooth muscle cells from Dahl rats. J Am Soc Nephrol 4:515, 1993